International Journal of
Medicine and Medical Sciences

  • Abbreviation: Int. J. Med. Med. Sci.
  • Language: English
  • ISSN: 2006-9723
  • DOI: 10.5897/IJMMS
  • Start Year: 2009
  • Published Articles: 535

Full Length Research Paper

Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study

Abiyie Zeleke
  • Abiyie Zeleke
  • Department of Pediatrics and Child Health, Debre Markos University, Debre Markos, Ethiopia.
  • Google Scholar


  •  Received: 26 May 2015
  •  Accepted: 22 July 2016
  •  Published: 30 November 2016

References

El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, Morris L, Ekström AM (2011). Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PloS one 6(3):e17518.
Crossref

 

Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, Bartlett JA, Crump JA, Reddy EA (2010). Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J. Acquired immune defic. Syndr. 54(4):368.
Crossref

 

Federal Ministry of Health (FMH) (2008). Guidelines for Pediatric HIV/AIDS Care and Treatment in Ethiopia, Addis Ababa. Federal HIV/AIDS Prevention and Control Office.

 

FHAPCO/MoH (2007). Single point prevalence estimate-calibrated output, FHAPCO/MoH, 2007.

 

FMOH (2010). Guide lines for HIV care/ART clinical mentoring in Ethiopia ,FMOH, August 2010

 

Holly R (2011). Treatment Failure in Children with HIV. J. Watch AIDS Clin. Care May 9, 2011.

 

Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, Kumar V, Ngin S, Nerrienet E, Zachariah R (2010). High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J. Int. AIDS Soc. 13(1):1.
Crossref

 

Prabhakar B, Banu A, Pavithra HB, Chandrashekhara P, Sasthri S (2011). Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy. Indian J. Sex Transm. Dis. 32(2):94.
Crossref

 

Sebunya R, Musiime V, Kitaka SB, Ndeezi G (2013). Incidence and risk factors for first line anti-retroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res. Ther. 10(1):1.
Crossref

 

Tigist B, Birkneh T, Alemayehu W (2012). Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC infect. Dis.12(1):1

 

Workneh N, Girma T, Woldie M (2009). Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiop. J. Health Sci. 19(2):75-82.

 

World Health organization (WHO) (2010). Guidelines for the use of antiretroviral agents in pediatric HIV infection.

 

World Health Organization (WHO) (2010). Panel on antiretroviral therapy and medical management of HIV infected children. Guidelines for the use antiretroviral agents in pediatric HIV infections.